Full-Time

Associate IS

Safety ART, ICSR Processing, Icma

Posted on 4/21/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Entry, Junior

Hyderabad, Telangana, India

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
SQL
Data Analysis
Requirements
  • Bachelor’s degree and 0 to 3 years of Life Science/Biotechnology/Pharmacology/Information Systems experience
  • Diploma and 4 to 7 years of Life Science/Biotechnology/Pharmacology/Information Systems experience
  • Strong analytical and problem-solving skills to diagnose and resolve system-related issues
  • Experience with managing data transfer processes and resolving issues related to stuck or delayed data files
  • Knowledge of testing methodologies and quality assurance standard processes
  • Proficiency in working with data analysis and QA tools
  • Knowledge of writing SQL will be helpful
Responsibilities
  • Supervise daily data processes to identify and resolve issues where files are delayed or stuck
  • Tackle system and data reconciliation issues, collaborating with teams to resolve root causes and implement solutions
  • Work with various internal and external teams to address system dependencies and mitigate bottlenecks
  • Document and maintain records of recurring issues, proposed fixes, and preventive measures to improve process reliability
  • Collaborate with stakeholders to provide updates and ensure visibility in issue resolution
  • Develop and refine dashboards or reports to track system performance and file flow metrics
  • Participate in regular team meetings to discuss challenges, insights, and recommendations for process improvement
  • Responsible for ensuring that data is adhering to the KCI metrics on a regular basis
  • Develop and implement test plans, scripts to validate system updates, patches and new deployments
  • Identify and document system bugs or discrepancies, collaborating with developers or vendors to resolve them
  • Perform regression testing to ensure updates or fixes do not negatively impact existing functionalities
  • Automate repetitive testing processes and improve testing efficiency
Desired Qualifications
  • Knowledge or some experience in database programming languages such as Oracle SQL and PL/SQL
  • Some understanding of API integrations such as MuleSoft
  • Outstanding written and verbal communication skills, and ability to explain technical concepts to non-technical clients
  • Sharp learning agility, problem solving and analytical thinking
  • Knowledgeable in SDLC, including requirements, design, testing, data analysis, change control
  • Knowledgeable in reporting tools (e.g. Tableau)
  • SAFe for Teams certification (preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a significant portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective therapeutic solutions and expanding its pipeline of potential new treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.